Millipore Sigma Vibrant Logo

GR11L Anti-IGF-IR (Ab-1) Mouse mAb (αIR3)

This Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) is validated for use in IF, IP, Neutralization Studies, Paraffin Sections, Immunoblotting for the detection of IGF-IR (Ab-1).

Anti-IGF-IR (Ab-1) Mouse mAb (αIR3): Ficha de dados de segurança do material (FDSM) ou ficha de segurança do material (FSM), certificado de análise (CA) e certificado de qualidade (CQ), dossiês e outros documentos disponíveis.

Sinônimos: Anti-IGF-IR, Anti-Insulin-Like Growth Factor Receptor

View Products on Sigmaaldrich.com
GR11L
Ver preços e disponibilidade

Panorama geral

Replacement Information

Tabela com principais espec.

Species ReactivityHostAntibody Type
HMMonoclonal Antibody

Preço e Disponibilidade

Número de catálogo DisponibilidadeEmbalagem Qtde/Emb. Preço Quantidade
GR11L-100UG
Verificando a disponibilidade...
—
Disponibilidade limitada Disponibilidade limitada
Insira quantidade 
Descontinuado
Quantidades limitadas disponíveis
Disponibilidade a ser confirmada
    Restante: será informado
      Restante: será informado
      Vai informar
      Contatar o serviço de atendimento ao cliente
      Contact Customer Service

      		 Ampola plástica 100 μg
      Recuperando preço...
      O preço não pôde ser recuperado
      Quantidade mínima necessária para ser múltipla de
      Maximum Quantity is
      Após finalização do pedido Mais informações
      Você salvou ()
       
      —
      Solicitar preço
      		 —
      Description
      OverviewRecognizes the ~130 kDa α and the ~90 kDa β subunits of IGF-I receptor.
      Catalogue NumberGR11L
      Brand Family Calbiochem®
      SynonymsAnti-IGF-IR, Anti-Insulin-Like Growth Factor Receptor
      References
      ReferencesRoth, R. 1988. Science 239, 1269.
      Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276.
      Rosen, O.M. 1987. Science 257, 1452.
      Rechler, M.M., and Nissley, S.P. 1986. Hormone Res. 24, 152.
      Ullrich, A., et al. 1986. EMBO J. 5, 2503.
      Zapf, S., and Froesch, E.R. 1986. Hormone Res. 24, 121.
      Humbel, R.E. 1984. I. Chemistry in Li Hormonal proteins and peptides. Vol 12, Chap. 4 (Academic Press, New York, 1984).
      Kull, F.C., et al.1983. J. Biol. Chem. 258, 6561.
      Product Information
      FormLyophilized
      FormulationLyophilized from 20 mM ammonium bicarbonate solution, 100 µg BSA .
      Negative controlHS27 cells
      Positive controlHepG2 cells
      PreservativeNone
      Quality LevelMQ100
      Applications
      Application ReferencesNeutralization Studies Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276. Kull, F.C., et al.1983. J. Biol. Chem. 258, 6561. Original Clone Kull, F.C., et al.1983. J. Biol. Chem. 258, 6561.
      Key Applications Immunofluorescence
      Immunoprecipitation
      Not Western Blot
      Not Paraffin Sections
      Neutralization Studies
      Application NotesImmunofluorescence (1-5 µg/ml)
      Immunoprecipitation (1 µg/sample)
      Neutralization Studies (1 µg/ml; see application references)
      Paraffin Sections (not recommended)
      Immunoblotting (not recommended)
      Application CommentsBlocks IGF-I binding to the IGF-I receptor. May also weakly cross-react with the insulin receptor (see application references). It also inhibits the growth of MCF-7 cells in culture suggesting the IGF-I receptor may be involved in autocrine regulation of cell growth (see application references). Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogenpartially purified, human placenta IGF-I receptor
      ImmunogenHuman
      CloneαIR3
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsReconstitute with sterile phosphate buffered saline (PBS), pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to a final concentration of 100 µg/ml. Lyophilized antibodies should be resuspended at 4°C with occasional gentle mixing for at least two h. Following reconstitution, aliquot and freeze (-20°C) or refrigerate (4°C) with 0.1% sodium azide. Freezing of aliquots is recommended for long term storage of reconstituted product. Avoid freeze/thaw cycles of solutions.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de catálogo GTIN
      GR11L-100UG 07790788053758

      Documentation

      Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) MSDS

      Título

      Ficha de Segurança de Produtos (MSDS) 

      Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) Certificados de análise

      TítuloNúmero do lote
      GR11L

      Referências

      Visão geral de referência
      Roth, R. 1988. Science 239, 1269.
      Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276.
      Rosen, O.M. 1987. Science 257, 1452.
      Rechler, M.M., and Nissley, S.P. 1986. Hormone Res. 24, 152.
      Ullrich, A., et al. 1986. EMBO J. 5, 2503.
      Zapf, S., and Froesch, E.R. 1986. Hormone Res. 24, 121.
      Humbel, R.E. 1984. I. Chemistry in Li Hormonal proteins and peptides. Vol 12, Chap. 4 (Academic Press, New York, 1984).
      Kull, F.C., et al.1983. J. Biol. Chem. 258, 6561.

      Citações

      Título
    • Rita Nahta, et al. (2005) Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Research 65, 11118-11128.
    • Daniel E. Syroid, et al. (1999) A role for insulin-like growth factor-I in the regulation of Schwann cell survival. Journal of Neuroscience 19, 2059-2068.
    • Donald M. Henricks, et al. (1998) Identification of insulin-like growth factor I in bovine seminal plasma and its receptor on spermatozoa: influence on sperm motility. Biology of Reproduction 59, 330-337.
      		•
      Ficha de dados

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision24-August-2007 RFH
      SynonymsAnti-IGF-IR, Anti-Insulin-Like Growth Factor Receptor
      ApplicationImmunofluorescence (1-5 µg/ml)
      Immunoprecipitation (1 µg/sample)
      Neutralization Studies (1 µg/ml; see application references)
      Paraffin Sections (not recommended)
      Immunoblotting (not recommended)
      DescriptionPurified mouse monoclonal antibody generated by immunizing SJL mice with the specified immunogen and fusing splenocytes with FO mouse myeloma cells (see application references). Recognizes the ~130 kDa α and the ~90 kDa β subunits of IGF-I receptor.
      BackgroundThe insulin-like growth factors (IGFs) or somatomedins are mitogenic peptides present in the plasma of human, rat, and other species. Two distinct but chemically related IGFs have been purified from human plasma: IGF-I (Somatomedin C) and IGF-II. They are single chain polypeptides with molecular weights of 7,640 and 7,471, respectively. Types I and II IGF receptors differ in their structure and in their peptide binding specificity. Type I IGF receptors are structurally homologous to insulin receptors and contain a-subunits (MW = 130,000) that bind peptide, and b-subunits (MW = 90,000), which have intrinsic tyrosine kinase activity. The protein-tyrosine kinase activity of the insulin receptor and, presumably the IGF-I receptor, is required for insulin to stimulate all of its biological responses in cells. Type II receptors are a single polypeptide (MW = 260,000), lack protein-tyrosine kinase activity, and have been shown to be identical to the mannose-6-phosphate receptor.
      HostMouse
      Immunogen speciesHuman
      Immunogenpartially purified, human placenta IGF-I receptor
      CloneαIR3
      IsotypeIgG₁
      Specieshuman
      Positive controlHepG2 cells
      Negative controlHS27 cells
      FormLyophilized
      FormulationLyophilized from 20 mM ammonium bicarbonate solution, 100 µg BSA .
      PreservativeNone
      CommentsBlocks IGF-I binding to the IGF-I receptor. May also weakly cross-react with the insulin receptor (see application references). It also inhibits the growth of MCF-7 cells in culture suggesting the IGF-I receptor may be involved in autocrine regulation of cell growth (see application references). Antibody should be titrated for optimal results in individual systems.
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsReconstitute with sterile phosphate buffered saline (PBS), pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to a final concentration of 100 µg/ml. Lyophilized antibodies should be resuspended at 4°C with occasional gentle mixing for at least two h. Following reconstitution, aliquot and freeze (-20°C) or refrigerate (4°C) with 0.1% sodium azide. Freezing of aliquots is recommended for long term storage of reconstituted product. Avoid freeze/thaw cycles of solutions.
      Toxicity Standard Handling
      ReferencesRoth, R. 1988. Science 239, 1269.
      Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276.
      Rosen, O.M. 1987. Science 257, 1452.
      Rechler, M.M., and Nissley, S.P. 1986. Hormone Res. 24, 152.
      Ullrich, A., et al. 1986. EMBO J. 5, 2503.
      Zapf, S., and Froesch, E.R. 1986. Hormone Res. 24, 121.
      Humbel, R.E. 1984. I. Chemistry in Li Hormonal proteins and peptides. Vol 12, Chap. 4 (Academic Press, New York, 1984).
      Kull, F.C., et al.1983. J. Biol. Chem. 258, 6561.
      Citation
    • Rita Nahta, et al. (2005) Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Research 65, 11118-11128.
    • Daniel E. Syroid, et al. (1999) A role for insulin-like growth factor-I in the regulation of Schwann cell survival. Journal of Neuroscience 19, 2059-2068.
    • Donald M. Henricks, et al. (1998) Identification of insulin-like growth factor I in bovine seminal plasma and its receptor on spermatozoa: influence on sperm motility. Biology of Reproduction 59, 330-337.
      		•
      Application referencesNeutralization Studies Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276. Kull, F.C., et al.1983. J. Biol. Chem. 258, 6561. Original Clone Kull, F.C., et al.1983. J. Biol. Chem. 258, 6561.